7 patents
Utility
Cell separation apparatus
21 Nov 23
Systems and methods herein are directed towards the separation of biologic material to obtain a target cell volume and/or cell concentration for harvesting.
Rolf Wolters, Anthony Yang, Josh Nelson, Stuart K. Williams
Filed: 18 Sep 17
Utility
Methods of transdifferentiation and methods of use thereof
4 Apr 23
Disclosed herein is a method for manufacturing a population of human insulin producing cells from non-pancreatic β-cells, wherein the resulting insulin producing cells have increased insulin content, or increased glucose regulated secretion of insulin, or a combination of both.
Sarah Ferber
Filed: 1 Apr 20
Utility
Prophylactic protection against viral infections
17 May 22
The present disclosure provides methods for prophylactically treating a subject for viral infections comprising topically administering a ranpirnase composition.
Luis Squiquera, Thomas Hodge, Jamie Sulley
Filed: 26 Jul 17
Utility
Transdifferentiated cell populations and methods of use thereof
13 Apr 21
Disclosed herein are methods for manufacturing transdifferentiated populations of non-pancreatic human insulin producing cells, and methods for enriching populations of non-pancreatic β-cells for cells comprising an enriched capacity for transcription factor-induced transdifferentiation into a pancreatic β-cell phenotype and function.
Sarah Ferber
Filed: 7 Nov 19
Utility
Cell populations, methods of transdifferentiation and methods of use thereof
16 Mar 21
The present invention provides methods for the sequential and temporally-regulated administration of pancreatic transcription factors to induce non-pancreatic cells to transdifferentiate and mature along the pancreatic β-cell lineage.
Sarah Ferber
Filed: 25 Apr 18
Utility
Prophylactic protection against viral infections, particularly HIV
16 Nov 20
An experiment has shown that ranpirnase is a microbicide.
Jamie Sulley, Luis Squiquera, David Sidransky, Tom Hodge
Filed: 27 Apr 17
Utility
Methods of transdifferentiation and methods of use thereof
1 Jun 20
Disclosed herein is a method for manufacturing a population of human insulin producing cells from non-pancreatic β-cells, wherein the resulting insulin producing cells have increased insulin content, or increased glucose regulated secretion of insulin, or a combination of both.
Sarah Ferber
Filed: 28 Nov 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first